Theranica’s 53,000-Patient Study Proves 30-Day Longitudinal Patterns Predict Migraines with 91% Precision24. September 2026
Gadgets Octave Bioscience Names Jennifer Mellum Vice President of Marketing as Precision Neurology Platform ScalesHealthradar2. September 2026 MENLO PARK, Calif.–(BUSINESS WIRE)–#MultipleSclerosis–Octave Bioscience, Inc., a commercial-stage precision medicine company pioneering biomarker-driven solutions for multiple sclerosis, Parkinson’s disease, and…
